Stock HINOON HIGHNOON LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Highnoon Laboratories Limited

Equities

HINOON

PK0070701013

Pharmaceuticals

End-of-day quote Pakistan S.E.
Other stock markets
 06:00:00 2024-04-22 pm EDT 		5-day change 1st Jan Change
536.3 PKR +0.87% Intraday chart for Highnoon Laboratories Limited -5.31% +6.29%
Apr. 09 Highnoon Laboratories Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Highnoon Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling and marketing of pharmaceutical and allied consumer products. The Company's product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Somno, Hitica, Apiban, Pidogrel-AP, Blokium DIU, Epliron, Sacuvia, Ivaset, Rivaro, Valforge and Herbesser. Its metabolic products include Xormet XR, MetFormin HCI, Diajard-MXR, Diajard-M and Diajard. The Company's gastroenterology products include Liv 52, Rabecid and Racedo. Its musculoskeletal products include Flexa Plus, Airtal ER and Tamadol. The Company's pediatric products include Bonisan, Cogniza, Flu Ace, Prospan and Tres Orix Forte. Its allergy products include Leviva and Kestine. Its Respiratory products include Combivair Forte, Sprahaler Respules, Foracort HFA Inhaler and Rotaflo.

Number of employees: 2,295

Sales per Business

PKR in Million2022Weight2023Weight Delta
Pharmaceutical
109.9 %
17,052 107.8 % 21,717 109.9 % +27.36%
Discount
-10.9 %
-1,518 -9.6 % -2,146 -10.9 % +41.36%
Toll Manufacturing
3.1 %
491 3.1 % 617 3.1 % +25.49%
Sales Return
-1.2 %
-100 -0.6 % -239 -1.2 % +139.75%
Sales Tax
-0.9 %
-109 -0.7 % -183 -0.9 % +66.80%

Sales per region

PKR in Million2022Weight2023Weight Delta
Pakistan
93.9 %
14,927 94.4 % 18,566 93.9 % +24.38%
Afghanistan
3.8 %
589 3.7 % 750 3.8 % +27.44%
United Arab Emirates
0.7 %
103 0.7 % 143 0.7 % +38.18%
France
0.4 %
50 0.3 % 82 0.4 % +64.01%
Dubai
0.4 %
20 0.1 % 78 0.4 % +294.67%
Iraq
0.2 %
61 0.4 % 45 0.2 % -26.24%
Tanzania
0.2 %
21 0.1 % 39 0.2 % +85.06%
Sudan
0.1 %
-- 22 0.1 % -
Kenya
0.1 %
15 0.1 % 21 0.1 % +33.58%
Cambodia
0.1 %
18 0.1 % 16 0.1 % -13.23%
Others
0.0 %
11 0.1 % 5 0.0 % -59.47%

Managers

Managers TitleAgeSince
Adeel Abbas Haideri CEO
 Chief Executive Officer - -
Ashfaq P. Alidina DFI
 Director of Finance/CFO - 20-03-31
Ali Sarwar CTO
 Chief Tech/Sci/R&D Officer - -
Ahmad Raza CTO
 Chief Tech/Sci/R&D Officer - -
Sajjad Hafeez Butt COO
 Chief Operating Officer - -
Mahnoor Ather IRC
 Investor Relations Contact - -
Azfar Haidrie PRN
 Corporate Officer/Principal - -
Zulfiqar Zaidi HRO
 Human Resources Officer - -
Kamran Ikram SAM
 Sales & Marketing - -
Iram Naila LAW
 General Counsel - 14-12-31

Members of the board

Members of the board TitleAgeSince
Tariq Wajid BRD
 Director/Board Member - 23-02-23
Tausif Ahmad Khan CHM
 Chairman - 83-12-31
Ghulam Hussain Khan BRD
 Director/Board Member - 88-02-29
Zainub Abbas BRD
 Director/Board Member - 00-09-02
Adeel Abbas Haideri CEO
 Chief Executive Officer - -
Taufiq Ahmed Khan BRD
 Director/Board Member 34 -
Romesh Elapata BRD
 Director/Board Member - 18-02-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 52,983,368 25,670,165 ( 48.45 %) 0 48.45 %

Shareholders

NameEquities%Valuation
National Investment Trust Ltd.
1.332 %
705,982 1.332 % 1 M ₨
MCB-Arif Habib Savings & Investments Ltd. (Invt Mgmt)
0.9392 %
497,641 0.9392 % 911 937 ₨
UBL Fund Managers Ltd.
0.6755 %
357,886 0.6755 % 655 833 ₨
Atlas Asset Management Ltd.
0.6319 %
334,786 0.6319 % 613 502 ₨
JS Investments Ltd. (Investment Management)
0.5178 %
274,369 0.5178 % 502 787 ₨
Al Meezan Investment Management Ltd.
0.4577 %
242,496 0.4577 % 444 379 ₨
Faysal Bank Ltd. (Investment Management)
0.4126 %
218,630 0.4126 % 400 644 ₨
Alfalah Asset Management Ltd.
0.1359 %
72,026 0.1359 % 131 989 ₨
NBP Fund Management Ltd.
0.1279 %
67,770 0.1279 % 124 190 ₨
HBL Asset Management Ltd.
0.0917 %
48,588 0.0917 % 89 038 ₨

Company contact information

Highnoon Laboratories Ltd.

Tricon Corporate Centre 9th Floor Jail Road

53700, Lahore

+

http://www.highnoon-labs.com
address Highnoon Laboratories Limited(HINOON)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
HIGHNOON LABORATORIES LIMITED Stock Highnoon Laboratories Limited
+5.37% 101M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.46% 659B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.23% 557B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.86% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.44% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.34% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+6.40% 215B
NOVARTIS AG Stock Novartis AG
+8.21% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.01% 200B
PFIZER, INC. Stock Pfizer, Inc.
-8.79% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. HINOON Stock
  4. Company Highnoon Laboratories Limited